BUBENDORF, Switzerland (July 21, 2022) — Switzerland-based CARBOGEN AMCIS, a pharmaceutical process development and Active Pharmaceutical Ingredient (API) manufacturing company, announced today the appointment of François Baduel as Vice President of Business Development, Sales & Marketing.
In his new role, François Baduel will lead the company’s overall sales and marketing operations. He will report directly to Pascal Villemagne, Chief Executive Officer, and will serve on the company’s executive management team as of July 1st.
The new Vice President of Business Development, Sales & Marketing will be responsible for developing strategic sales plans based on the company’s goals that will promote business development, sales growth and customer satisfaction for the organization as well as continue to target specific market segments and geographic locations to expand the company’s business. He will also have under his responsibility the marketing department in order to pursue the development of this strategic area to meet company’s objectives.
Baduel's arrival follows the appointment of Pascal Villemagne as CARBOGEN AMCIS CEO, who previously held the position of VP sales and commercial
“François Baduel brings 29 years of experience of business development and commercial management in various CDMOs and will surely be an important asset to our company, helping us to develop our growth and business further,” Commented Pascal Villemagne, CARBOGEN AMCIS CEO. “I am delighted to welcome him on board. I know very well the stakes of this position and François be able to tackle the challenge perfectly,
"I am thrilled to join a leading provider of drug development and commercialization services such as CARBOGEN AMCIS,” said François Baduel. “I look forward to collaborating with the team to support the company’s expansion all in supporting our customers in their critical path to drug development and commercialization.”
Baduel holds a Chemical Engineering Master from UMIST in Manchester and Master’s in business degree from the HEC business school in Paris. He also is a graduate engineer from the Lille (France) School of Chemistry (ENSCL)
CARBOGEN AMCIS (www.carbogen-amcis.com) is a leading service provider offering a portfolio of drug development and commercialization services to the pharmaceutical and biopharmaceutical industries across all stages of clinical development and product life cycle. Our integrated services and innovative chemistry solutions support timely and safe drug development, allowing customers to better optimize available resources. CARBOGEN AMCIS is a wholly owned subsidiary of Dishman Carbogen Amcis Limited, Ahmedabad, India.
Dishman Carbogen Amcis Limited (www.imdcal.com) is a global outsourcing partner for the pharmaceutical industry, offering a portfolio of development, scale-up and manufacturing services. Dishman Carbogen Amcis group improves its customers’ businesses by providing a range of development and manufacturing solutions at locations in Europe and in India.